Emerging Diagnostic Techniques and Therapeutic Strategies in Urological Oncology
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 3
Special Issue Editor
Interests: reconstructive urology; urologic oncology; prostate cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Urological cancers—including prostate, bladder, kidney, and testicular malignancies—pose complex diagnostic challenges due to their diverse presentations and often subtle early-stage symptoms. Accurate and timely diagnosis is critical for improving patient outcomes and guiding effective treatment decisions.
This Special Issue focuses on the latest advances in diagnostic methodologies for urological oncology. We aim to showcase innovative approaches such as advanced imaging technologies, biomarker discovery, liquid biopsy, molecular and genetic profiling, and the integration of artificial intelligence in diagnostic workflows. Contributions that explore how these techniques improve early detection, risk stratification, and disease monitoring are particularly encouraged.
We welcome original research articles and comprehensive reviews that provide novel insights into diagnostic strategies for urological cancers.
By gathering cutting-edge research and expert perspectives, this Special Issue seeks to advance the science of medical diagnosis in urological oncology and support the development of more precise, patient-centered care.
Dr. Francesco Chierigo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer
- screening
- biomarkers
- genetic testing
- imaging
- PSMA
- artificial intelligence
- radical prostatectomy
- radiotherapy
- hormonal therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
